Larimar Therapeutics Overview
Larimar Therapeutics Target Price
Analysts' 12-month price predictions for LRMR.
Share Price
$3.2
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-12-17 | H.C. WainwrightEdward White | $15 |  368.8% upside |  |
| 2024-10-30 | CitigroupSamantha Semenkow | $14 | 337.5% upside | |
| 2024-10-03 | WedbushLaura Chico | $22 | 587.5% upside | |
| 2024-04-03 | Leerink PartnersJoori Park | $25 | 681.3% upside | |
| 2022-12-13 | Citigroup | $4 | 25% upside | |